This activity is expired and is no longer available for CME credit.


Potential Role of Aflibercept as the Next VEGF Antagonist in the Management of Diabetic Macular Edema

Author(s)/Faculty: Diana V. Do, MD; Quan Dong Nguyen, MD MSc; Yasir J. Sepah, MBBS
Release Date: 11/1/2013Expiration Date: 10/31/2014
Credit Type: CMENumber of Credits: 0
Content Type: MonographProvider:
Several treatment strategies have been used to halt or decelerate disease progression and decrease visual loss associated with diabetic macular edema (DME), including pituitary gland destruction, tight glycemic control, adequate blood pressure control, laser photocoagulation and, more recently, the use of vascular endothelial growth factor (VEGF) antagonists...